期刊文献+

枸菊明目汤联合羟苯磺酸钙治疗非增值型糖尿病视网膜病变的临床观察 被引量:2

下载PDF
导出
摘要 目的:观察枸菊明目汤联合羟苯磺酸钙治疗非增值型糖尿病视网膜病变(NPDR)的临床疗效。方法:120例糖尿病视网膜病变的志愿受试者随机分为两组,各60例,两组均进行糖尿病基础治疗,对照组予以口服羟苯磺酸钙胶囊,治疗组在此基础上加用枸菊明目汤,治疗3个月,对比分析治疗前后眼底评分及总有效率。结果:治疗后,两组眼底评分均降低,治疗组总体有效率为90.0%,对照组为81.7%,治疗组均优于对照组(P<0.05)。结论:枸菊明目汤联合羟苯磺酸钙治疗NPDR可显著改善患者眼底病变,提高患者生活质量。
出处 《医学理论与实践》 2018年第5期671-672,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献7

二级参考文献113

  • 1贺光玉,甄东户.复方丹参滴丸治疗非增殖期糖尿病视网膜病变的临床观察[J].兰州大学学报(医学版),2013,39(4):76-78. 被引量:13
  • 2姚沛雨,申进亮,龙新胜.降糖明目片治疗非增殖型糖尿病视网膜病变临床观察[J].光明中医,2007,22(11):61-63. 被引量:7
  • 3Centers for Disease Control and Prevention (CDC). Blindness caused by diabetes--Massachusetts, 1987-1994.
  • 4MMWR Morb Mortal Wkly Rep, 1996, 45:937-941.
  • 5Yau J W, Rogers S L, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012, 35: 556-564.
  • 6Xie X, Xu L, Yang H, et al. Frequency of diabetic retinopathy in the adult population in China: the Beijing Eye Study 2001. Int Ophthalmol, 2009, 29:485-493.
  • 7Xu J, Wei W B, Yuan M X, et al. Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina, 2012, 32:322-329.
  • 8Wang F H, Liang Y B, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology, 2009, 116:461-467.
  • 9ACCORD Study Group, ACCORD Eye Study Group, Chew E Y, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. New Engl J Med, 2010, 363:233-244.
  • 10Aiello L P, Vignati L, Sheetz M J, et al. Oral protein kinase C 13 inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1392 eyes) with diabetic retinopathy in the Protein Kinase C 15 Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C 15 Inhibitor-Diabetic Retinopathy Study 2. Retina, 2011, 31:2084-2094.

共引文献359

同被引文献29

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部